National Respiratory Medicines Optimisation Conference

These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.

PM Healthcare events are Quality Assured by the University of Bradford 


Event Name National Respiratory Medicines Optimisation Conference
Location Royal College of General Practitioners, 30 Euston Square, London, NW1 2FB
Start Date 9:30am 20/03/2024
Finish Date 4:00pm 20/03/2024
Booking Closes No longer taking bookings
Places Available
Event Description

Session Synopses: 

Psychological safety for pharmacists in the NHS - A pathway for managing stress

Ivan Hollingsworth - Director, Centric Consultants Limited

In recent years psychological safety has consistently been reported as the strongest predictor of workplace culture. The problem is how few in healthcare truly understand what it is, why it is so important and how to develop it in their teams and organisations. Pharmacy needs to embrace psychological safety and lead the way in healthcare, for the benefit of the profession, the patients, and the wider system. This session will ensure delegates have clarity regarding what psychological safety is, why it should be the number one priority and how to positively impact it in their workplaces.


Antimicrobial Stewardship Update

Prof Diane Ashiru-Oredope - Lead Pharmacist, Antimicrobial Resistance, UK Health Security Agency; Deputy Chief Scientist, Royal Pharmaceutical Society; Honorary Chair and Professor of Pharmaceutical Public Health, University of Nottingham

The session will provide an update on national actions to tackle antimicrobial resistance through stewardship interventions. 


Empowering Pharmacists - Developing your Portfolio to match your personal circumstances

Ijeoma Udeagbala-Okumah - Lead Respiratory Pharmacist, Frimley Health NHS Trust

Practical ways to optimise opportunities to meet your professional goals.


What will tomorrow’s Specialised Commissioning for Respiratory Medicines look like?

Mohammed Asghar - Frimley Health and Care ICS Associate Director of Pharmacy: Prescribing Governance

This Session will look at how the process of delegation of specialised commissioning from NHSE to local systems is progressing, what changes are envisioned to arise and how these changes may impact upon respiratory disease services in future. 


Virtual Wards – What is the role of the Pharmacy?

Amy Vigar - Advanced Pharmacist Home Ward Frailty - Leeds Community Healthcare NHS Trust

The story of the development of the Leeds Home Ward Frailty Pharmacy Model through critical and frequently asked questions. What is a virtual ward? What is the need for a virtual ward? How is it working? What is the experience like? What have you learnt?


Workshop: In a world of change and pressure, how can we become more resilient?

Ivan Hollingsworth - Director, Centric Consultants Limited

Increasingly in modern-day society, certain words seem to have been misappropriated by either the ill-informed or those who seek to exert power over others; resilience is one of these words.This session will aim to detoxify, de-weaponize and break the myths around resilience; through understanding it is not an attribute or characteristic you are born with, rather an output of your mindset, behaviours, and environment.

Walk through the 6 pillars of resilience and build strategies that can help you to become better able to deal with life’s challenges and adversities.


Biologics and Asthma centres 

Ravijyot Saggu - Medicines Optimisation Lead Pharmacist; Chief Pharmaceutical Officer’s Clinical fellow '21/'22;
Chair UKCPA Respiratory committee; Clinical member - Respiratory Clinical Reference Group, NHSE; Honorary clinical lecturer, University College London, Central London Community Healthcare trust

With the advent of specialist service delegation, this session will outline the use of biologic agents, role of asthma centres and when to refer into specialist services for optimal asthma management.


Managing Asthma in Teenagers - Challenges and potential solutions

Suzanne Bailey - ICS Children and Young Peoples Clinical Respiratory Lead/Senior Specialist CYP Asthma Practitioner, NHS Surrey Heartlands

Being a teenager is not always easy!  During this time, a young person goes through significant physiological and psychological changes that can impact on asthma control and severity.  Enabling and supporting children to self-manage their asthma from an early age can assist them with their understanding as a young person and facilitate a smooth transition into adult services.  Being aware of adherence barriers for young people such as complicated treatment plans or embarrassment around using spacers (if using pMDI’s) can assist the HCP work more efficiently with the young person when performing asthma reviews.  Young people with asthma that leave the family home to attend university are often not prepared to manage their condition; even practical things such as ordering repeat prescription may be challenging at first.  Let’s give young people a good start as they grow into adults. 


Lung health and Community Pharmacy – a perfect partnership

Darush Attar-Zadeh BPharm (Independent Prescriber) - Clinical Fellow Respiratory Pharmacist – NWL Integrated Care Board, Co-Chair Taskforce for Lung Health Medicines Optimisation Working Group, Co-Chair of the CYP Pharmacy asthma group (London Asthma Leadership and Implementation Group)

Community Pharmacies are a crucial partner to Primary Care in helping to support respiratory patients. Are we maximising respiratory opportunities to support patients and help ease some of the pressures on primary care? This session will share some case study examples of good MDT working and shed light on incentive schemes that are available to the pharmacies.


National Medicines Optimisation Opportunities in Respiratory

Lynn Elsey - Lead respiratory/ severe asthma pharmacist, Manchester University NHS Foundation Trust

Respiratory medicines optimisation opportunities and the role the Pharmacist can play in achieving these and how they link with the integrated care board priorities:

  • improving medicines-related patient safety
  • delivering value to the system
  • improving patient outcomes
  • supporting equity of access
  • supporting NHS recovery through increasing capacity
  • reducing health inequalities
  • improving sustainability


The Hewitt Review - What does it mean for Pharmacy? 

Malcolm Harrison - Chief Executive at Company Chemists' Association

The session will cover:

  • an overview of the review and its findings,
  • update of the community pharmacy network,
  • thoughts on the future of the network, and
  • what the findings and recommendation of the review mean for pharmacy. 


Medicines value – how do we drive improvements in patient outcomes and ensure value to the NHS?

Suzy Heafield - Pharmacist and Independent Healthcare Consultant at Millfield Healthcare Consultancy Limited (formerly Head of Medicines Value and Delivery at NHS England)

Pharmacy teams have a key role to play in ensuring best value from medicines. This session will cover how pharmacy teams can work with other stakeholders to drive improvements in patient outcomes and experience and ensure that the best value is achieved from the NHS’s significant investment in medicines.


National drivers – the All Party Parliamentary Group (APPG) Respiratory health 

Ravijyot Saggu  - Medicines Optimisation Lead Pharmacist; Chief Pharmaceutical Officer’s Clinical fellow '21/'22;
Chair UKCPA Respiratory committee; Clinical member - Respiratory Clinical Reference Group, NHSE; Honorary clinical lecturer, University College London, Central London Community Healthcare trust

This session will look at national influences on respiratory disease and revisit the APPG Respiratory Health reports (including Improving asthma outcomes in the UK) and recommendations. 


Air Pollution and Asthma Attacks – What can we advise?

Dr Paul Pfeffer - Primary affiliation: Consultant Respiratory Physician, St Bartholomew's Hospital, Barts Health NHS Trust

Secondary affiliation: Honorary Senior Lecturer, Queen Mary University of London

This session will consider the mechanisms by which air pollution causes asthma exacerbations and how self-management can potentially help patients protect themselves from harm from air pollution.


Non-Invasive Ventilation: CPAP and BiPAP in Acute Medicine

Georgia Bousi - Respiratory Nurse Specialist, UCLH

Non-Invasive Ventilation is the provision of ventilatory support via an interface/facemask and when used correctly in the acute setting it can correct a hypoxemic or hypercapnic respiratory failure. The benefits not only transpire to the patients but also to the NHS with cuts in cost and length of overall stay to name a few.  NIV has been and will continue changing the way we deliver care and improve patient outcome. 


This event will be funded by the following companies through event sponsorship, sponsored satellite sessions and stand sponsorship. These companies have had no input into the design or content of the conference agenda (other than their own sessions) but will be in attendance on the day.

Headline Sponsors: AstraZeneca, Chiesi Ltd

Stand Sponsors: Aspire Pharma, Lupin Healthcare, ONE Health Communications Ltd, Orion Pharma (UK) Ltd, STADA UK Thornton & Ross Ltd, TriOn Pharma Limited, Zentiva Pharma UK Ltd

Agenda Download Agenda PDF
Contact Name Client Services
More Details Email for more details.
Your booking is always provisional until we confirm it!
Join Waiting List
Website by MAXX Design

© 2024 Pharman | All rights reserved | Site Map | Accessibility | Privacy and Cookie Policy | Terms & Conditions


This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.